Atley’s automated production module allows for a standardised and reproducible production of the pharmaceuticals used in Targeted Alpha Therapy, a promising treatment for disseminated cancer. The module will enhance clinical research in this field and is essential in order to enable the future treatment of cancer patients using this method. Targeted Alpha Therapy has the potential to improve and save millions of lives. For this to happen, Atley's technology is needed.